Accuray, Inc. (ARAY)
1.05
+0.06
(+6.43%)
USD |
NASDAQ |
Dec 10, 14:37
Accuray EPS Diluted (Quarterly): -0.1822 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 1.717 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.68M |
| Revenue (Quarterly) | 93.94M |
| Total Expenses (Quarterly) | 115.62M |
| Enterprise Value | 227.02M |
| Gross Profit Margin (Quarterly) | 28.69% |
| Profit Margin (Quarterly) | -23.08% |
| Earnings Yield | -15.25% |
| Operating Earnings Yield | 0.15% |
| Normalized Earnings Yield | -12.61 |